UK regulators say extra AstraZeneca vaccine data highlights efficacy in elderly

Retrieved on: 2021-02-05 13:18:45

Tags for this article:

Health sciences

Medicine

Health

Medical research

Clinical trials

Department of Health and Social Care

Medicines and Healthcare products Regulatory Agency

Development of COVID-19 vaccines

United Kingdom

Click the tags to see associated articles and topics

UK regulators say extra AstraZeneca vaccine data highlights efficacy in elderly. View article details on HISWAI: https://www.reuters.com/article/health-coronavirus-astrazeneca-mhra/update-2-uk-regulators-say-extra-astrazeneca-vaccine-data-highlights-efficacy-in-elderly-idUSL8N2KB3F6

Excerpt

LONDON (Reuters) - British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed ...

Article found on: www.reuters.com

View Original Article